Navigation

Ovarian cancer (metastatic) - bevacizumab (with paclitaxel and carboplatin) [ID435]

Bevacizumab in combination with paclitaxel and carboplatin for the first-line chemotherapy treatment of ovarian cancer

Status: History
Expected date of issue: May 2013
Referral date: January 2011
Process: STA
Notes:

Scoped within Batch 15

Topic area:
 

NICE project team

Executive Lead: Gill Leng
Technical Lead: Matthew Dyer
Communications manager: Laura Gibson
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 17 August 2012
1st appraisal committee meeting: 20 November 2012
2nd appraisal committee meeting 06 February 2012
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
27 February 2012 The invitations to participate and submitting of evidence will begin during late June 2012. The first Appraisal Committee discussion will take place on 20 November 2012. The second Appraisal Committee discussion (if required) will take place on 6 February 2013.
4 November 2011 This appraisal has been temporarily suspended. This is to further investigate the most appropriate treatment regimen to appraise and whether a revised scope should be issued.
11 May 2011 Please note that following on from advice received from the manufacturer, this appraisal has been rescheduled to align with latest regulatory expectations.  Therefore, we now anticipate that the appraisal will begin during early September 2011. The deadline for submissions is expected in approximately early November 2011.
Top


 

Key documents

This page was last updated: 24 May 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.